These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Differential effects of L-deprenyl on MPP+- and MPTP-induced dopamine overflow in microdialysates of striatum and nucleus accumbens. Wu WR; Zhu ZT; Zhu XZ Life Sci; 2000 Jun; 67(3):241-50. PubMed ID: 10983868 [TBL] [Abstract][Full Text] [Related]
8. Chronic effects of single intrastriatal injections of 6-hydroxydopamine or 1-methyl-4-phenylpyridinium studied by microdialysis in freely moving rats. Espino A; Cutillas B; Tortosa A; Ferrer I; Bartrons R; Ambrosio S Brain Res; 1995 Oct; 695(2):151-7. PubMed ID: 8556325 [TBL] [Abstract][Full Text] [Related]
9. Release of dopamine by perfusion with 1-methyl-4-phenylpyridinium ion (MPP(+)) into the striatum is associated with hydroxyl free radical generation. Obata T; Yamanaka Y; Kinemuchi H; Oreland L Brain Res; 2001 Jul; 906(1-2):170-5. PubMed ID: 11430875 [TBL] [Abstract][Full Text] [Related]
10. In vivo protection of striatal dopaminergic system against 1-methyl-4-phenylpyridinium neurotoxicity by phenobarbital. Vizuete ML; Merino M; Cano J; Machado A J Neurosci Res; 1997 Aug; 49(3):301-8. PubMed ID: 9260741 [TBL] [Abstract][Full Text] [Related]
11. Neuroprotective effects of the novel D3/D2 receptor agonist and antiparkinson agent, S32504, in vitro against 1-methyl-4-phenylpyridinium (MPP+) and in vivo against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): a comparison to ropinirole. Joyce JN; Presgraves S; Renish L; Borwege S; Osredkar T; Hagner D; Replogle M; PazSoldan M; Millan MJ Exp Neurol; 2003 Nov; 184(1):393-407. PubMed ID: 14637109 [TBL] [Abstract][Full Text] [Related]
13. Dopamine-releasing action of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and 1-methyl-4-phenylpyridine (MPP+) in the neostriatum of the rat as demonstrated in vivo by the push-pull perfusion technique: dependence on sodium but not calcium ions. Sirinathsinghji DJ; Heavens RP; McBride CS Brain Res; 1988 Mar; 443(1-2):101-16. PubMed ID: 3258784 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of brain vesicular monoamine transporter (VMAT2) enhances 1-methyl-4-phenylpyridinium neurotoxicity in vivo in rat striata. Staal RG; Sonsalla PK J Pharmacol Exp Ther; 2000 May; 293(2):336-42. PubMed ID: 10773000 [TBL] [Abstract][Full Text] [Related]
15. Increased extracellular glutamate evoked by 1-methyl-4-phenylpyridinium [MPP(+)] in the rat striatum is not essential for dopaminergic neurotoxicity and is not derived from released glutathione. Foster SB; Tang H; Miller KE; Dryhurst G Neurotox Res; 2005; 7(4):251-63. PubMed ID: 16179262 [TBL] [Abstract][Full Text] [Related]
17. Inhibition by dizocilpine (MK-801) of striatal dopamine release induced by MPTP and MPP+: possible action at the dopamine transporter. Clarke PB; Reuben M Br J Pharmacol; 1995 Jan; 114(2):315-22. PubMed ID: 7881731 [TBL] [Abstract][Full Text] [Related]
18. Histamine-3 receptor antagonists reduce superoxide anion generation and lipid peroxidation in rat brain homogenates. Badenhorst HE; Maharaj DS; Malan SF; Daya S; van Dyk S J Pharm Pharmacol; 2005 Jun; 57(6):781-5. PubMed ID: 15969934 [TBL] [Abstract][Full Text] [Related]
19. Effects of alpha-phenyl-N-tert-butyl nitrone and N-acetylcysteine on hydroxyl radical formation and dopamine depletion in the rat striatum produced by d-amphetamine. Wan FJ; Tung CS; Shiah IS; Lin HC Eur Neuropsychopharmacol; 2006 Feb; 16(2):147-53. PubMed ID: 16061357 [TBL] [Abstract][Full Text] [Related]
20. Evidence for hydroxyl radical scavenging action of nitric oxide donors in the protection against 1-methyl-4-phenylpyridinium-induced neurotoxicity in rats. Banerjee R; Saravanan KS; Thomas B; Sindhu KM; Mohanakumar KP Neurochem Res; 2008 Jun; 33(6):985-95. PubMed ID: 17763941 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]